CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olshan, A. F.
Right arrow Articles by Bell, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olshan, A. F.
Right arrow Articles by Bell, D. A.
Cancer Epidemiology Biomarkers & Prevention Vol. 9, 185-191, February 2000
© 2000 American Association for Cancer Research

GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 Polymorphisms, Tobacco Use, and the Risk of Head and Neck Cancer1

Andrew F. Olshan2, Mark C. Weissler, Mary A. Watson and Douglas A. Bell

Department of Epidemiology, School of Public Health [A. F. O.] and Division of Otolaryngology/Head and Neck Surgery, Department of Surgery, School of Medicine [A. F. O., M. C. W.], University of North Carolina, Chapel Hill, North Carolina 27599, and Laboratory of Computational Biology and Risk Assessment, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [M. A. W., D. A. B.]

Squamous cell carcinoma of the head and neck (SCCHN), including the oral cavity, pharynx, and larynx, provides an ideal tumor model to investigate gene-environment interaction. We conducted a hospital-based case-control study including 182 cases with newly diagnosed SCCHN and 202 controls with nonneoplastic conditions of the head and neck that required surgery. Lifetime tobacco use and risk of SCCHN were evaluated in relation to the polymorphisms of GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1. The main effects of genotype were associated with a slightly increased risk of SCCHN for GSTP1 [age-, race-, and sex-adjusted odds ratio (OR), 1.2; confidence interval (CI), 0.8–1.9], GSTT1 (OR, 1.2; CI, 0.7–2.3), and NAT1 (OR, 1.1; CI, 0.7–1.7). The joint effects of genotype combinations showed some excess risk for the combination of the GSTM1 null genotype and the CYP1A1 Ile/Val polymorphism (OR, 2.6; CI, 0.7–10.3). The analysis of the joint effects (interaction) of the "at-risk" genotypes and tobacco use did not reveal any interaction on either the multiplicative or additive scale for GSTM1, GSTP1, or CYP1A1. However, there was a suggestion of an interaction on the additive scale between the pack-years of tobacco use and the GSTT1 null genotype. The combined heterozygote and homozygote NAT1*10 genotypes also had a suggestive interaction with tobacco smoking history. The results of this study suggest a possible gene-environment interaction for certain carcinogen metabolizing enzymes, but larger studies that fully evaluate the interaction are needed.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
M. Hashibe, P. Brennan, S. Benhamou, X. Castellsague, C. Chen, M. P. Curado, L. D. Maso, A. W. Daudt, E. Fabianova, V. Wunsch-Filho, et al.
Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
J Natl Cancer Inst, May 16, 2007; 99(10): 777 - 789.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. S. Peters, M. D. McClean, C. J. Marsit, B. Luckett, and K. T. Kelsey
Glutathione S-Transferase Polymorphisms and the Synergy of Alcohol and Tobacco in Oral, Pharyngeal, and Laryngeal Carcinoma.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2196 - 2202.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
A. J. De Roos, N. Rothman, M. Brown, D. A. Bell, G. S. Pittman, W. R. Shapiro, R. G. Selker, H. A. Fine, P. M. Black, and P. D. Inskip
Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.
Neuro-oncol, April 1, 2006; 8(2): 145 - 155.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. F. Masson, L. Sharp, S. C. Cotton, and J. Little
Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review
Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
Z Ye, H Song, and Y Guo
Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis
J. Med. Genet., May 1, 2004; 41(5): 360 - 365.
[Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu
An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology
Cancer Res., March 15, 2004; 64(6): 2251 - 2257.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Hashibe, P. Brennan, R. C. Strange, R. Bhisey, I. Cascorbi, P. Lazarus, M. B. O. Ophuis, S. Benhamou, W. D. Foulkes, T. Katoh, et al.
Meta- and Pooled Analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 Genotypes and Risk of Head and Neck Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1509 - 1517.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. M. Shaw, V. Nelson, D. M. Iovannisci, R. H. Finnell, and E. J. Lammer
Maternal Occupational Chemical Exposures and Biotransformation Genotypes as Risk Factors for Selected Congenital Anomalies
Am. J. Epidemiol., March 15, 2003; 157(6): 475 - 484.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. J. Duell, E. A. Holly, P. M. Bracci, M. Liu, J. K. Wiencke, and K. T. Kelsey
A Population-Based, Case-Control Study of Polymorphisms in Carcinogen-Metabolizing Genes, Smoking, and Pancreatic Adenocarcinoma Risk
J Natl Cancer Inst, February 20, 2002; 94(4): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Fronhoffs, T. Bruning, E. Ortiz-Pallardo, P. Brode, B. Koch, V. Harth, A. Sachinidis, H. M. Bolt, C. Herberhold, H. Vetter, et al.
Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck
Carcinogenesis, September 1, 2001; 22(9): 1405 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. B. J. Smith, P. A. Harper, J. M. Y. Wong, M. S. M. Lam, K. R. Reid, D. Petsikas, and T. E. Massey
Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms
Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 839 - 853.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. A. Geisler and A. F. Olshan
GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review
Am. J. Epidemiol., July 15, 2001; 154(2): 95 - 105.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2000 by the American Association for Cancer Research.